Navigation Links
Gene pattern may identify kidney transplant recipients who don't need life-long anti-rejection drugs
Date:5/24/2010

Researchers have identified a distinct pattern of gene expression in the largest reported group of kidney transplant recipients who have not rejected the transplant kidneys even though they stopped taking anti-rejection drugs. This finding may help identify other transplant recipients who could safely reduce or end use of immunosuppressive therapy. In 2008, more than 80,000 people in the United States were living with a kidney transplant.

The findings come from the Immune Tolerance Network (ITN), an international research consortium supported by the National Institute of Allergy and Infectious Diseases (NIAID) and the National Institute of Diabetes and Digestive and Kidney Diseases, of the National Institutes of Health, and the Juvenile Diabetes Research Foundation International. The research team included three lead investigators, Kenneth Newell, M.D., Ph.D., of Emory University in Atlanta; Laurence Turka, M.D., of Beth Israel Deaconess Medical Center and Harvard Medical School in Boston; and Vicki Seyfert-Margolis, Ph.D., the former Chief Scientific Officer of ITN and currently at the Food and Drug Administration. Their report appears online in the Journal of Clinical Investigation.

"The immunosuppressive therapy regimens that organ transplant recipients must endure have toxic side effects and increase the recipients' vulnerability to infections and cancer," says NIAID Director Anthony S. Fauci, M.D. "This study holds promise for identifying kidney transplant recipients who might be able to minimize or withdraw from their use of anti-rejection drugs. However, large, prospective studies will be necessary to determine if the same biomarkers identified in the current study are reliable predictors of immune tolerance."

Following a kidney transplant, recipients must be placed on immunosuppressive therapy or their immune systems will reject the transplanted organ. However, these drugs suppress the entire immune system, reducing an
'/>"/>

Contact: Julie Wu
wujuli@niaid.nih.gov
301-402-1663
NIH/National Institute of Allergy and Infectious Diseases
Source:Eurekalert

Page: 1 2 3 4

Related medicine news :

1. Genetic Pattern May Predict Leukemia Relapse
2. Genetic pattern that predicts leukemia relapse discovered
3. Research identifies patterns of CD24, a novel biomarker for non-small cell lung carcinomas
4. Study Offers Insights Into Male Pattern Baldness
5. Bees Can Be Trained to Recognize Face-Like Patterns
6. New Paperback Dating Advice Book, Love in 90 Days, Reveals 16 Men's Dead-End Dating Patterns and What To Do About Them
7. Researchers find new patterns in H1N1 deaths
8. Wistar-led research team discovers genetic pattern that indicates early-stage lung cancer
9. Australian researchers identify a new disease
10. McGill-UBC project creates mouse grimace scale to help identify pain in humans and animals
11. Simple Test May Identify Breast Cancer Subtypes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/29/2015)... ... June 29, 2015 , ... Blue ... two leaders with the Commercial Markets division, which includes the company’s commercial health ... Minnesota-headquartered companies with regional, national and international reach. Mary Ellen Anderson now holds ...
(Date:6/29/2015)... ... June 29, 2015 , ... Minneapolis Saint Paul Plumbing, ... area, provides money-saving tactics during a season of increased water and air conditioning ... conservation and other economical practices. , According to the U.S. Department of ...
(Date:6/29/2015)... ... 29, 2015 , ... National Access Cannabis (NAC), ... to Health Canada's medical cannabis program, today officially opened its first Ottawa location ... medical marijuana system works. Members are connected with a physician for a medical ...
(Date:6/29/2015)... ... 2015 , ... Before launching the next product to join the BPI Sports line-up, BPI took ... One simple question was asked: “What do you want from your pre-workout?” The most popular ... to create the next generation of pre-training powders to help people power through even the ...
(Date:6/29/2015)... ... ... Visiting retirement communities and interviewing at-home caregivers has just gotten easier, courtesy of ... on http://www.SeniorsGuideOnline.com . , The helpful “cheat” sheets, like the ones available in ... and nursing home communities . , “’What to Ask When Visiting a Retirement ...
Breaking Medicine News(10 mins):Health News:Blue Cross and Blue Shield of Minnesota announces two new leadership appointments within its Commercial Markets division 2Health News:Blue Cross and Blue Shield of Minnesota announces two new leadership appointments within its Commercial Markets division 3Health News:Save Energy: MSP Plumbing, Heating & Air Endorses Efficiency 2Health News:Save Energy: MSP Plumbing, Heating & Air Endorses Efficiency 3Health News:National Access Cannabis Opens Flagship Ottawa Care Centre 2Health News:National Access Cannabis Opens Flagship Ottawa Care Centre 3Health News:The All-New PUMP HD™ by BPI Sports is Here to Energize Your Workouts 2Health News:New Checklists and Question Sheets for Visiting Retirement Communities, Interviewing Home Health Caregivers Available From Seniors Guide 2Health News:New Checklists and Question Sheets for Visiting Retirement Communities, Interviewing Home Health Caregivers Available From Seniors Guide 3
... N.J., Oct. 23 Amneal Pharmaceuticals, a ... and Indoco Remedies, an India-based API and ... finalization of,a joint venture partnership to develop, ... United States market. The initial product pipeline,will ...
... ... Changed, SAN DIEGO, Oct. 23 Imagenetix, Inc. (OTC,Bulletin Board: IAGX), ... series of warrants that are scheduled to,expire on October 23, 2007. The ... Warrant holders will have the right to have their warrants extended,until October ...
... Today for a "Medicare-Operated" Drug Plan, WASHINGTON, ... should have the option of choosing prescription drug,coverage ... consumer,exploitation that plagues the current Medicare Part D ... Union and the Medicare,Rights Center in a report ...
... Management,Services, Inc. (Sedgwick CMS) announced a gift today ... auxiliary support organization for Walter,Reed Army Medical Center ... Walter Reed,Society,s Operation Iraqi Freedom/Operation Enduring Freedom (OIF/OEF),Support ... families of soldiers,receiving treatment at WRAMC for wounds ...
... Standards Panel (HITSP) has identified a set of,standards ... medical,information secure in an electronic environment. The standards ... only be used by authorized,personnel for official purposes., ... and privacy architecture is,the latest in a series ...
... the first time, researchers at the University of Pennsylvania ... from false memories, providing a better understanding of how ... epilepsy patients retain cognitive function., The study, the first ... human memories, is available online in the journal Psychological ...
Cached Medicine News:Health News:Amneal Pharmaceuticals & Indoco Remedies Finalize Long Term Joint Venture Agreement to Develop and Market Generic Ophthalmic Pharmaceuticals 2Health News:Amneal Pharmaceuticals & Indoco Remedies Finalize Long Term Joint Venture Agreement to Develop and Market Generic Ophthalmic Pharmaceuticals 3Health News:Imagentix Offers Extension of Warrants 2Health News:Report: Medicare-Administered Drug Benefit Would be More Affordable, Comprehensive, Stable than Current Private Insurance-Run Drug Benefit 2Health News:Report: Medicare-Administered Drug Benefit Would be More Affordable, Comprehensive, Stable than Current Private Insurance-Run Drug Benefit 3Health News:Sedgwick CMS Gift Supports Walter Reed Patients, Families 2Health News:HITSP Defines Overarching Set of Healthcare Security and Privacy Standards 2Health News:Penn researchers pinpoint the brain waves that distinguish false memories from real ones 2
(Date:6/29/2015)... , June 29, 2015  Isis Pharmaceuticals, Inc. (NASDAQ: ... added to the Russell 1000 Index, effective June 26, ... the large-cap segment of the U.S. equity universe. It ... includes approximately 1000 of the largest securities based on ... membership. "We are pleased to be added ...
(Date:6/29/2015)... Axxess , an industry leader in ... vendor accredited by the American Nursing Credentialing Center – ... agencies select the right revenue cycle management (RCM) system ... business. Research by American Health Information Management ... a decrease in productivity of 54.4 - 69 percent ...
(Date:6/29/2015)... 29, 2015  Arbor Solution has added another ... high-powered, multi-functional M2150 offers two platforms: ... Core i5-4402E 1.6 GHz processor and i5-4422E ... and computing performance. Integrated Intel® HD Graphics 4600 ... suited for graphics-intense applications in operating rooms, clinical ...
Breaking Medicine Technology:ISIS Pharmaceuticals Promoted to the Large-Cap Russell 1000 Index 2ISIS Pharmaceuticals Promoted to the Large-Cap Russell 1000 Index 3Axxess Releases eGuide for Home Health Agencies, Revenue Cycle Management: What You Must Do Now - to Succeed! 2Arbor Solution Introduces Multi-Function Medical Workstation with Large 21.5" True Flat Touch Screen 2Arbor Solution Introduces Multi-Function Medical Workstation with Large 21.5" True Flat Touch Screen 3
... N.J., July 05, 2007 /PRNewswire/ -- Results ... open-label, Phase,3 study showed that 77 percent ... 600 mg tablets with,100 mg ritonavir (PREZISTA/r) ... of antiretroviral (ARV) agents, reached a,plasma viral ...
... 2007 - ZIOPHARM,Oncology, Inc. (NASDAQ: ZIOP) announces ... II trial of ZIO-201 (isophosphoramide mustard,- IPM) ... at the,European Society of Medical Oncology (ESMO) ... The abstract entitled, "Phase-I/II,Study of IPM (ZIO-201) ...
Cached Medicine Technology:New Phase 3 Study Published in The Lancet Evaluates Efficacy and,Safety of Prezista/Ritonavir vs. Kaletra as Part of HIV Combination,Therapy in Treatment-Experienced Adults With HIV 2New Phase 3 Study Published in The Lancet Evaluates Efficacy and,Safety of Prezista/Ritonavir vs. Kaletra as Part of HIV Combination,Therapy in Treatment-Experienced Adults With HIV 3New Phase 3 Study Published in The Lancet Evaluates Efficacy and,Safety of Prezista/Ritonavir vs. Kaletra as Part of HIV Combination,Therapy in Treatment-Experienced Adults With HIV 4New Phase 3 Study Published in The Lancet Evaluates Efficacy and,Safety of Prezista/Ritonavir vs. Kaletra as Part of HIV Combination,Therapy in Treatment-Experienced Adults With HIV 5New Phase 3 Study Published in The Lancet Evaluates Efficacy and,Safety of Prezista/Ritonavir vs. Kaletra as Part of HIV Combination,Therapy in Treatment-Experienced Adults With HIV 6New Phase 3 Study Published in The Lancet Evaluates Efficacy and,Safety of Prezista/Ritonavir vs. Kaletra as Part of HIV Combination,Therapy in Treatment-Experienced Adults With HIV 7New Phase 3 Study Published in The Lancet Evaluates Efficacy and,Safety of Prezista/Ritonavir vs. Kaletra as Part of HIV Combination,Therapy in Treatment-Experienced Adults With HIV 8Positive ZIO-201 Interim Phase II Sarcoma Data Presented at,European Society for Medical Oncology 2Positive ZIO-201 Interim Phase II Sarcoma Data Presented at,European Society for Medical Oncology 3
Nordan tying forceps, straight, titanium, 6.5 mm tying platforms....
Harms-Tuebingen tying forceps, straight, 6 mm tying platforms....
Castroviejo straight tying forceps, straight shafts, 5 mm tying platforms, wide handle....
Shepard tying forceps, round curved platform 8 mm, 8.5 cm....
Medicine Products: